Ifosfamide-induced Nephrotoxicity in Children: Critical Review of Predictive Risk Factors

Authors:

Abstract
Ifosfamide is widely used in the treatment of pediatric solid tumors. Its main adverse effects are various forms of renal tubular and glomerular damage. Many risk factors have been proposed to play a role in the development and severity of nephrotoxicity in children receiving ifosfamide, among which are 1) patient9s age, 2) cumulative ifosfamide dose, 3) concurrent administration of cis or carboplatinum, 4) unilateral nephrectomy, and 5) method of ifosfamide administration. However, presently there is no consensus regarding the weight of each one of them. Therefore, we critically reviewed the major studies that have evaluated the different risk factors in an attempt to determine the relative importance of each. Cumulative ifosfamide doses of ≥60 g/m2 appears to be the most consistent independent predictor for both the development and the severity of nephrotoxicity, whereas a younger age (2should be considered carefully, especially in children <5 years of age.

This publication has 14 references indexed in Scilit: